Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Labenz

Showing results (61-70 of 144) with videos related to

Pageof 15
Sort By:
Medicina (Kaunas, Lithuania)|May 27, 2023
Validation of the CLIF-C OF Score and CLIF-C ACLF Score to Predict Transplant-Free Survival in Patients with Liver Cirrhosis and Concomitant Need for Intensive Care Unit TreatmentMichael Nagel, Ruben Westphal, Max Hilscher, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 17, 2023
Higher scores in the Clinical Frailty Scale are associated with covert and overt hepatic encephalopathy in patients with cirrhosisEva Maria Schleicher, Leonard Kaps, Jörn M Schattenberg, et al.
Hepatology Communications|October 4, 2022
A higher FIB-4 index is associated with an increased incidence of renal failure in the general populationEva Maria Schleicher, Simon Johannes Gairing, Peter Robert Galle, et al.
Health and Quality of Life Outcomes|January 15, 2020
Impact of acute-on-chronic liver failure and decompensated liver cirrhosis on psychosocial burden and quality of life of patients and their close relativesMichael Nagel, Christian Labenz, Marcus A Wörns, et al.
European Journal of Internal Medicine|September 19, 2019
Health-related quality of life in patients with compensated and decompensated liver cirrhosisChristian Labenz, Gerrit Toenges, Jörn M Schattenberg, et al.
Scientific Reports|September 17, 2024
Impairment of health-related quality of life among people with type 2 diabetes and advanced liver fibrosisMaurice Michel, Jesús Funuyet-Salas, Michelle Doll, et al.
Hepatology Communications|November 9, 2019
Cardiovascular Risk Categories in Patients With Nonalcoholic Fatty Liver Disease and the Role of Low-Density Lipoprotein CholesterolChristian Labenz, Jürgen H Prochaska, Yvonne Huber, et al.
United European Gastroenterology Journal|January 11, 2024
Obesity and harmful alcohol consumption are predictors for advanced liver disease in the disease management program for type 2 diabetesMaurice Michel, Michelle Doll, Nastasia Albert, et al.
AIDS (London, England)|July 18, 2022
Prevalence and risk factors of nonalcoholic steatohepatitis with significant fibrosis in people with HIVMaurice Michel, Christian Labenz, Alisha Wahl, et al.
United European Gastroenterology Journal|May 9, 2019
Terlipressin and albumin combination treatment in patients with hepatorenal syndrome type 2Marc Nguyen-Tat, Julia Jäger, Johannes Wilhelm Rey, et al.
Pageof 15

Showing results (61-70 of 144) with videos related to

Sort By:
Pageof 15
Medicina (Kaunas, Lithuania)|May 27, 2023
Validation of the CLIF-C OF Score and CLIF-C ACLF Score to Predict Transplant-Free Survival in Patients with Liver Cirrhosis and Concomitant Need for Intensive Care Unit TreatmentMichael Nagel, Ruben Westphal, Max Hilscher, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 17, 2023
Higher scores in the Clinical Frailty Scale are associated with covert and overt hepatic encephalopathy in patients with cirrhosisEva Maria Schleicher, Leonard Kaps, Jörn M Schattenberg, et al.
Hepatology Communications|October 4, 2022
A higher FIB-4 index is associated with an increased incidence of renal failure in the general populationEva Maria Schleicher, Simon Johannes Gairing, Peter Robert Galle, et al.
Health and Quality of Life Outcomes|January 15, 2020
Impact of acute-on-chronic liver failure and decompensated liver cirrhosis on psychosocial burden and quality of life of patients and their close relativesMichael Nagel, Christian Labenz, Marcus A Wörns, et al.
European Journal of Internal Medicine|September 19, 2019
Health-related quality of life in patients with compensated and decompensated liver cirrhosisChristian Labenz, Gerrit Toenges, Jörn M Schattenberg, et al.
Scientific Reports|September 17, 2024
Impairment of health-related quality of life among people with type 2 diabetes and advanced liver fibrosisMaurice Michel, Jesús Funuyet-Salas, Michelle Doll, et al.
Hepatology Communications|November 9, 2019
Cardiovascular Risk Categories in Patients With Nonalcoholic Fatty Liver Disease and the Role of Low-Density Lipoprotein CholesterolChristian Labenz, Jürgen H Prochaska, Yvonne Huber, et al.
United European Gastroenterology Journal|January 11, 2024
Obesity and harmful alcohol consumption are predictors for advanced liver disease in the disease management program for type 2 diabetesMaurice Michel, Michelle Doll, Nastasia Albert, et al.
AIDS (London, England)|July 18, 2022
Prevalence and risk factors of nonalcoholic steatohepatitis with significant fibrosis in people with HIVMaurice Michel, Christian Labenz, Alisha Wahl, et al.
United European Gastroenterology Journal|May 9, 2019
Terlipressin and albumin combination treatment in patients with hepatorenal syndrome type 2Marc Nguyen-Tat, Julia Jäger, Johannes Wilhelm Rey, et al.
Pageof 15